Cargando…

Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study

BACKGROUND: Many studies have indicated that hospitalization and readmissions occur frequently, especially among people living with HIV. The aim of the study was to determine the effectiveness of a programmed and structured pharmaceutical intervention, based on “CMO PC model” to reduce the readmissi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramos, Maria Isabel Guzman, Garcia, Mercedes Manzano, Mª de las Aguas Robustillo, Cortés, Pizarraya, Antonio Gutiérrez, Morillo-Verdugo, Ramón
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2021
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638845/ https://www.ncbi.nlm.nih.gov/pubmed/34231351 http://dx.doi.org/10.37201/req/025.2021

Ejemplares similares

Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2019)

High level of medication regimen complexity index correlate with worse quality of life in people living with HIV
por: Contreras-Macías, Enrique, et al.
Publicado: (2021)

Beliefs and attitudes about deprescription in older HIV-infected patients: ICARD Project
por: Giménez, Reyes Serrano, et al.
Publicado: (2020)

Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2022)

Potentially inappropriate medications according to Marc, STOPP and PRISCUS criteria in a cohort of elderly HIV+ patients. The COMMPI project
por: García-Lloret, Patricia, et al.
Publicado: (2022)

Determination of a cutoff value for medication regimen complexity index to predict polypharmacy in HIV+ older patient
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2019)

Clinical Impact of the Capacity-Motivation-Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019–2020
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2022)

CmoNAC1 in pumpkin rootstocks improves salt tolerance of grafted cucumbers by binding to the promoters of CmoRBOHD1, CmoNCED6, CmoAKT1;2 and CmoHKT1;1 to regulate H(2)O(2), ABA signaling and K(+)/Na(+) homeostasis
por: Peng, Yuquan, et al.
Publicado: (2023)

The CMO's Periodic Table: A Renegade's Guide to Marketing
por: Neisser, Drew
Publicado: (2015)

Evaluation of Patient Experience with a Model of Coordinated Telematic Pharmaceutical Care Between Hospital and Rural Pharmacies in Spain [Response To Letter]
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2023)

Evaluation of Patient Experience With A Model of Coordinated Telematic Pharmaceutical Care Between Hospital and Rural Pharmacies in Spain: A Proof of Concept
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2023)

Determinants of the CmoB carboxymethyl transferase utilized for selective tRNA wobble modification
por: Kim, Jungwook, et al.
Publicado: (2015)

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020)

Implementation of a novel home delivery service during pandemic
por: Peláez Bejarano, Ana, et al.
Publicado: (2021)

S-Adenosyl-S-carboxymethyl-l-homocysteine: a novel cofactor found in the putative tRNA-modifying enzyme CmoA
por: Byrne, Robert T., et al.
Publicado: (2013)

Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain
por: Cantudo-Cuenca, M. D., et al.
Publicado: (2021)

Person-centred pharmaceutical care reduces emergency readmissions
por: Blagburn, Julia, et al.
Publicado: (2016)

1786. Characterizing Antibiotic Use in Patients with Hematologic and Oncologic Malignancies Transitioned to Comfort Measures Only (CMO) During Hospital Admission
por: Chan, Michelle, et al.
Publicado: (2022)

GWAS Reveals a Novel Candidate Gene CmoAP2/ERF in Pumpkin (Cucurbita moschata) Involved in Resistance to Powdery Mildew
por: Alavilli, Hemasundar, et al.
Publicado: (2022)

Corticosterone Methyl Oxidase Type 1 (CMO1) Deficiency Due to CYP11B2 Mutation: Two Case Reports
por: Ur Rehman, Saad, et al.
Publicado: (2023)

Prevalence of prescription of the Top-10 drug classes to avoid in elderly people living with HIV in a real practice cohort
por: Macías, Enrique Contreras, et al.
Publicado: (2020)

Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

The minimal effective dose of cis-9-cetylmyristoleate (CMO) in persons presenting with knee joint pain: A double-blind, randomized, placebo-controlled trial
por: Lee, Sang Chul, et al.
Publicado: (2017)

Genome-wide identification of NHX (Na(+)/H(+) antiporter) gene family in Cucurbita L. and functional analysis of CmoNHX1 under salt stress
por: Shen, Changwei, et al.
Publicado: (2023)

Readmission rates in HIV-associated burkitt lymphoma patients in the USA: a nationwide readmission database (NRD) analysis
por: Tuin, Ashley M., et al.
Publicado: (2023)

Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers
por: Myers, Alyson K., et al.
Publicado: (2021)

5‐Oxyacetic Acid Modification Destabilizes Double Helical Stem Structures and Favors Anionic Watson–Crick like cmo(5)U‐G Base Pairs
por: Strebitzer, Elisabeth, et al.
Publicado: (2018)

ALTERAÇÕES NOS SUBTIPOS DE MONÓCITOS (CMO, IMO E NCMO) NA COVID-19 E SUA RELAÇÃO COM A GRAVIDADE DA DOENÇA
por: Walter, LO, et al.
Publicado: (2021)

Readmission rates and predictors of avoidable readmissions in older adults in a tertiary care centre
por: Samuel, Stephen V., et al.
Publicado: (2022)

Concurrent Use of Comedications Reduces Adherence to Antiretroviral Therapy Among HIV-Infected Patients
por: Cantudo-Cuenca, Maria Rosa, et al.
Publicado: (2014)

Readmission Risk Assessment Tool (RRAT) for Decreasing 30-Day Readmission Rates in Total Joint Arthroplasty (TJA) and Predicting Readmission
por: Dundon, John, et al.
Publicado: (2023)

Readmission of Patients to Acute Psychiatric Hospitals: Influential Factors and Interventions to Reduce Psychiatric Readmission Rates
por: Owusu, Ernest, et al.
Publicado: (2022)

Have rates of readmission for COPD been overestimated?
por: White, Patrick T, et al.
Publicado: (2016)

Physician characteristics correlate with hospital readmission rates
por: Skolka, Michael, et al.
Publicado: (2020)

Thirty‐day hospital readmission rate, reasons, and risk factors after acute inpatient cancer rehabilitation
por: Tennison, Jegy M., et al.
Publicado: (2021)

Readmission rates in not-for-profit vs. proprietary hospitals before and after the hospital readmission reduction program implementation
por: Birmingham, Lauren E., et al.
Publicado: (2018)

Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions
por: Kichloo, Asim, et al.
Publicado: (2021)

Readmission of Patients to Acute Psychiatric Hospitals: Determining Factors and Interventions to Reduce Inpatient Psychiatric Readmission Rates.
por: Owusu, E., et al.
Publicado: (2023)

726 Readmission rate associated with Staphylococcus aureus bacteremia
por: Lee, Jean, et al.
Publicado: (2014)

Dementia and Hospital Readmission Rates: A Systematic Review
por: Pickens, Sabrina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_odh4jqm050qq0rfpr7sote1kn3